Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)

15.16
Delayed Data
As of Apr 27
 -0.16 / -1.04%
Today’s Change
11.41
Today|||52-Week Range
21.75
-17.70%
Year-to-Date
No recent news for Amphastar Pharmaceuticals Inc.

Today’s Trading

Previous close15.32
Today’s open15.32
Day’s range15.11 - 15.47
Volume164,986
Average volume (3 months)387,763
Market cap$702.7M
Dividend yield--
Data as of 3:59pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-18.71%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+1.45%
P/E ratio68.9
Price/Sales3.43
Price/Book2.15

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...0.000.00%
VSARVersartis Inc-0.10-0.50%
OMEROmeros Corp+0.18+1.10%
TGTXTG Therapeutics Inc-0.20-1.65%
Data as of 3:59pm ET, 04/27/2017

Financials

Next reporting dateMay 17, 2017
EPS forecast (this quarter)$0.07
Annual revenue (last year)$255.2M
Annual profit (last year)$10.5M
Net profit margin4.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, COO &
Chief Scientist
Zi Ping Luo
CEO, Director &
Chief Science Officer
Yong Feng Zhang
Corporate headquarters
Rancho Cucamonga, California

Forecasts